tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gena Wang, 253 are a BUY (61.86%), 120 are a HOLD (29.34%), 36 are a SELL (8.8%).
Analyst Gena Wang, currently employed at BARCLAYS, carries an average stock price target met ratio of 56.18% that have a potential upside of 30.34% achieved within 171 days. Previously, Gena Wang worked at JEFFERIES, LEERINK.
Gena Wang’s has documented 782 price targets and ratings displayed on 51 stocks. The coverage is on Healthcare, Energy, Technology sectors.
Most recent stock forecast was given on NTLA, Intellia Therapeutics at 06-Oct-2026.
Analyst best performing recommendations are on SGTX (SIGILON THERAPEUTICS).
The best stock recommendation documented was for SGTX (SIGILON THERAPEUTICS) at 12/29/2020. The price target of $624 was fulfilled within 2 days with a profit of $137.8 (28.34%) receiving and performance score of 141.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Jul-2025
$225
$69.06 (44.29%)
$315
9 days ago
(02-Nov-2026)
4/10 (40%)
$60 (36.36%)
11
Buy Since 17-Dec-2018
$323
$167.06 (107.13%)
$429
9 days ago
(02-Nov-2026)
14/17 (82.35%)
$158 (95.76%)
319
Buy Since 28-Jun-2024
$380
$224.06 (143.68%)
$450
9 days ago
(02-Nov-2026)
1/6 (16.67%)
$215 (130.30%)
110
Buy Since 30-Oct-2026
$315
$159.06 (102.00%)
$333
12 days ago
(30-Oct-2026)
6/7 (85.71%)
$150 (90.91%)
153
Buy Since 20-Sep-2022
$280
$124.06 (79.56%)
$345
12 days ago
(30-Oct-2026)
31/39 (79.49%)
$115 (69.70%)
180
Which stock is Gena Wang most bullish on?
What Year was the first public recommendation made by Gena Wang?
